INSULIFE AS
Signals
- Driftsunderskudd 2024 Siste driftsresultat er negativt (−13,0 mill kr).
- Nylig endring 2026-02-05 Aksjekapital registrert 2026-02-05.
INSULIFE AS is registered as a limited company in Oslo, Oslo with organisation number 925128554. The business is classified under manufacture of pharmaceutical preparations (NACE 21.200). The company was incorporated in 2020. Registered share capital is NOK 72,000, divided into 72403417 shares. The company's stated purpose is: “Utvikle, eie, produsere, markedsføre og drive salg av spray baserte legemidler samt det som står i forbindelse med dette. Selskapet skal også kunne delta i andre virksomheter med økonomiske formål.”. The most recent filed accounts, for the 2024 financial year, show NOK 56,000 in revenue and NOK −13.0m in operating profit.
Key figures · 2024
Financial health · 2024
Who owns INSULIFE AS?
INSULIFE AS has 20+ registered shareholders:
- WESSEL CAPITAL LLC 23.5%
- TRANSDERMAL DELIVERY SOLUTIONS COR 22.1%
- PHARMAMENTOR AS 8.5%
- SIRO CLINPHARM PRIVATE LIMITED 3.5%
- SCANPIPE ENGINEERING AS 3.3%
- SILVERCOIN INDUSTRIES AS 2.8%
- SKADI AS 2.7%
- 3T HOLDING AS 2.2%
- SMERUD MEDICAL RESEARCH INTERNATIONAL AS 1.7%
- CHRISTIAN HENRIK THEISTE 1.4%
- KONSTRUKT HOLDING AS 1.2%
- LETRON AS 1.0%
- CAMACA AS 1.0%
- MOMENT HOLDING AS 0.8%
- TROND DAHL-PEDERSEN 0.8%
- MARIA PATRICIA CONDE 0.8%
- ANDREAS NÆRDAL 0.7%
- VELU HOLDING AS 0.6%
- TANNLEGENE BENTE OG VEGARD BERG AS 0.6%
- MOHAMED ALAMOODI 0.5%
Frequently asked questions about INSULIFE AS
Who owns INSULIFE AS?
WESSEL CAPITAL LLC is the largest registered owner, with 23.5%.
What is the revenue of INSULIFE AS?
INSULIFE AS had revenue of NOK 56,000 in 2024.
Who is the general manager of INSULIFE AS?
Åge Nærdal is registered as general manager of INSULIFE AS.
Where is INSULIFE AS based?
INSULIFE AS has its business address in Oslo.
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.